High-Plex Predictive Marker Discovery for Melanoma Immunotherapy-Treated Patients Using Digital Spatial Profiling.
Maria I TokiChristopher R MerrittPok Fai WongJames W SmithyHarriet M KlugerKonstantinos N SyrigosGiang T OngSarah E WarrenJoseph M BeechemDavid L RimmPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
DSP technology shows high concordance with QIF and validates based on both regression and outcome assessment. Using the high-plex capacity, we found a series of expression patterns associated with outcome, including that the expression of PD-L1 in macrophages is associated with response.